This Article Full Text Full Text (PDF) All Versions of this Article: 26/6/1207    most recent 01.ATV.0000217632.98717.a0v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Handy, D. E. Articles by Loscalzo, J. Search for Related Content PubMed PubMed Citation Articles by Handy, D. E. Articles by Loscalzo, J. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB NITRIC OXIDE Related Collections Endothelium/vascular type/nitric oxide Other Vascular biology

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:1207.)
© 2006 American Heart Association, Inc.

Brief Reviews

Nitric Oxide and Posttranslational Modification of the Vascular Proteome

S-Nitrosation of Reactive Thiols

Diane E. Handy; Joseph Loscalzo

From the Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass.

Correspondence to Joseph Loscalzo, Brigham and Women’s Hospital, Harvard Medical School, 75 Francis St, Boston, MA 02115. E-mail jloscalzo{at}partners.org

Series Editor: Joseph Loscalzo Previous Brief Review in this Series:

•Kim-Shapiro DB, Schlechter AN, Gladwin MT. Unraveling the reactions of nitric oxide, nitrite, and hemoglobin in physiology and therapeutics. 2006;26:697–705.

Nitric oxide (NO·) is known to exert its effects via guanylyl cyclase and cyclic GMP- dependent pathways and by cyclic GMP-independent pathways, including the posttranslational modification of proteins. Much ongoing research is focused on defining the mechanisms of NO·-mediated protein modification, the identity and function of the modified proteins, and the significance of these changes in health and disease. S-nitrosation or thionitrite formation has only been found on a limited number of residues in a subset of proteins in in vitro and in vivo studies. Protein S-nitrosation also appears to be reversible. There are several theories about the in vivo S-nitrosating agent, and most suggest a role for oxidation products of NO· in this process. Flux in cellular S-nitrosoprotein pools appears to be regulated by NO· availability and is redox-sensitive. An analysis of S-nitrosation in candidate proteins has clarified the mechanism by which NO· regulates enzymatic and cellular functions. These findings suggest the utility of using proteomic methods to identify unique targets for protein S-nitrosation to understand further the molecular mechanisms of the effects of NO·.

Nitric oxide (NO·) is known to exert its effects via guanylyl cyclase and cyclic GMP- dependent pathways and by cyclic GMP-independent pathways, including the posttranslational modification of proteins. Much ongoing research is focused on defining the mechanisms of NO·-mediated protein modification, the identity and function of the modified proteins, and the significance of these changes in health and disease. Specific findings suggest the utility of using proteomic methods to identify unique targets for protein S-nitrosation to understand further the molecular mechanisms of the effects of NO·.

Key Words: endothelial cells • nitric oxide • posttranslational modification • proteomics • S-nitrosation

This article has been cited by other articles:

				J. D. Erusalimsky and S. Moncada Nitric Oxide and Mitochondrial Signaling: From Physiology to Pathophysiology Arterioscler. Thromb. Vasc. Biol., December 1, 2007; 27(12): 2524 - 2531. [Abstract] [Full Text] [PDF]

				J. Sun, M. Morgan, R.-F. Shen, C. Steenbergen, and E. Murphy Preconditioning Results in S-Nitrosylation of Proteins Involved in Regulation of Mitochondrial Energetics and Calcium Transport Circ. Res., November 26, 2007; 101(11): 1155 - 1163. [Abstract] [Full Text] [PDF]

				M. Mayr, J. Zhang, A. S. Greene, D. Gutterman, J. Perloff, and P. Ping Proteomics-based Development of Biomarkers in Cardiovascular Disease: Mechanistic, Clinical, and Therapeutic Insights Mol. Cell. Proteomics, October 1, 2006; 5(10): 1853 - 1864. [Full Text] [PDF]